Skip to main content

Advertisement

Log in

Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

“Side population” (SP) cells, which pump out the fluorescent dye H33342 via the ABCG2 transporter, define a putative stem/progenitor cell population in the mammary gland. Breast cancer SP cells recently isolated from the MCF-7 cell line possess similar properties and may represent stem cell-like cancer cells. This study extends SP cell analysis to a broad panel of human breast cancer cell lines and investigates the expression of differentiation-associated markers in isolated cancer SP cells. Expression of ABCG2 was determined in 16 breast cancer cell lines by quantitative RT-PCR, Western blotting and immunohistochemistry. Subsequently, all cell lines were screened for the presence of SP cells. Human breast cancer cell lines commonly express ABCG2. ABCG2-immunoreactivity was clearly restricted to rare cancer cells in several cell lines including Cal-51. Analysis of H33342-labeled Cal-51 cells revealed a small fraction of putative SP cells accounting for one percent of all cells. The genuine nature of Cal-51 SP cells was unambiguously verified by demonstrating a 30-fold increased ABCG2-expression in isolated Cal-51 SP cells. During in vitro expansion, Cal-51 SP cells generated heterologous non-SP (NSP) cells and ABCG2-expression declined dramatically. In contrast, NSP cells failed to sustain proliferation. Freshly isolated Cal-51 SP cells also exhibited increased expression of Muc1 and CALLA. Noteworthy, non-malignant mammary epithelial SP cells lack these differentiation markers, highlighting fundamental differences between non-malignant and breast cancer-derived SP cells. In summary, we established Cal-51 SP cells as a novel in vitro model to study differential gene expression in breast cancer-derived SP and NSP cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988

    Article  PubMed  CAS  Google Scholar 

  2. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506–5511

    Article  PubMed  CAS  Google Scholar 

  3. Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063–6071

    Article  PubMed  CAS  Google Scholar 

  4. Liu BY, McDermott SP, Khwaja SS, Alexander CM (2004) The transforming activity of Wnt effectors correlates with their ability to induce accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 101:4158–4163

    Article  PubMed  CAS  Google Scholar 

  5. Scharenberg CW, Harkey MA, Torok-Storb B (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507–512

    Article  PubMed  CAS  Google Scholar 

  6. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17:1253–70

    Article  PubMed  CAS  Google Scholar 

  7. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco M, Dale TC, Smalley MJ (2003) Functional and molecular characterization of mammary side population cells. Breast Cancer Res 5:R1-R8

    Article  PubMed  Google Scholar 

  8. Clarke R, Spence K, Anderson E, Howell A, Okano H, Potten CS (2005) A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277:443–456

    Article  PubMed  CAS  Google Scholar 

  9. Behbod F, Xian W, Shaw CA, Hilsenbeck SG, Tsimelzon A, Rosen JM (2006) Transcriptional profiling of mammary gland side population cells. Stem cells 24:1065–1074

    Article  PubMed  CAS  Google Scholar 

  10. Jonker JW, Freeman J, Bolscher E, Musters S, Alvi AJ, Titley I, Schinkel AH, Dale TC (2005) Contribution of the ABCG2 Transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem cells 23:1059–1065

    Article  PubMed  CAS  Google Scholar 

  11. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11:127-129

    Article  PubMed  CAS  Google Scholar 

  12. Challen GA, Little MH (2006) A side order of stem cells: The SP phenotype. Stem cells 24:3–12

    Article  PubMed  Google Scholar 

  13. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes H33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22–28

    PubMed  CAS  Google Scholar 

  14. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101:781–786

    Article  PubMed  CAS  Google Scholar 

  15. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK (2004) A distinct „side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228–14233

    Article  PubMed  CAS  Google Scholar 

  16. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219

    Article  PubMed  CAS  Google Scholar 

  17. Haraguchi N, Utsunomiya T, Inoues H, Tanaka F, Mimori K, Barnard GH, Mori M (2006) Characterization of a side population of cancer cells from human gastrointestinal system. Stem cells 24:506–513

    Article  PubMed  CAS  Google Scholar 

  18. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103:11154–11159

    Article  PubMed  CAS  Google Scholar 

  19. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H (2006) Side population purified from hepatocellular carcinoma harbours cancer stem cell-like properties. Hepatology 44:240–251

    Article  PubMed  CAS  Google Scholar 

  20. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM (2007) WNT/ß-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104:618–623

    Article  PubMed  CAS  Google Scholar 

  21. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, Yamashita S (2007) Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148:1797–1803

    Google Scholar 

  22. Hill RP (2006) Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66:1891–1896

    Article  PubMed  CAS  Google Scholar 

  23. Setoguchi T, Taga T, Kondo T (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414–415

    PubMed  CAS  Google Scholar 

  24. Locke M, Heywood M, Fawell S, Mackenzie IC (2005) Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 65:8944–8950

    Article  PubMed  CAS  Google Scholar 

  25. Böcker W, Moll R, Poremba C, Holland R, vanDiest PJ, Dervan P, Burger H, Wai D, Diallo RI, Brand B, Herbst H, Schmidt A, Lerch MM, Buchwallow IB. (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept. Lab Invest 82:737–745

    PubMed  Google Scholar 

  26. Uphoff CC, Drexler HG (2005) Detection of mycoplasma contamination. Methods Mol Biol 290:13–23

    PubMed  CAS  Google Scholar 

  27. von Wasilewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A (1997) Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 45:1455–1459

    Google Scholar 

  28. Diestra JE, Scheffer GL, Catala I, Maliepaard M, Schellens JHM, Scheper RJ, Gema-Lluch JR, Izquierdo MA (2002) Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198:213–219

    Article  PubMed  CAS  Google Scholar 

  29. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60:47–50

    PubMed  CAS  Google Scholar 

  30. Ifergan I, Scheffer GL, Assaraf YG (2005) Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. Cancer Res 65:10952–10958

    Article  PubMed  CAS  Google Scholar 

  31. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H (2007) Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 6:92–97

    PubMed  CAS  Google Scholar 

  32. Nakanishi T, Bailey-Dell KJ, Hassel BA, Shiozawa K, Sullivan DM, Turner J, Ross DD (2006) Novel 5′ UTR region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: Implication for drug resistance, tissue-specific expression and alternative promotor usage. Cancer Res 66:5007–5011

    Article  PubMed  CAS  Google Scholar 

  33. Imai Y, Ishikawa E, Asada S, Sugimoto Y (2005) Estrogen-mediated post-transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596–604

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthias Christgen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christgen, M., Ballmaier, M., Bruchhardt, H. et al. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 306, 201–212 (2007). https://doi.org/10.1007/s11010-007-9570-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-007-9570-y

Keywords

Navigation